According to the Controlled Substances Act, schedule 1 drugs have:
- High potential for abuse
- Currently no medical use in the United States
- A lack of accepted safety for use of the drug or other substance under medical supervision.
Our AMA urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods. This should not be viewed as an endorsement of state-based medical cannabis programs, the legalization of marijuana, or that scientific evidence on the therapeutic use of cannabis meets the current standards for a prescription drug product.